Open Access
Original contribution
Issue
Parasite
Volume 19, Number 1, February 2012
Page(s) 63 - 70
DOI https://doi.org/10.1051/parasite/2012191063
Published online 15 February 2012
  1. Asencion Diez M.D., Demonte A., Giacomelli J., Garay S., Rodrigues D., Hofmann B., Hecht H.J., Guerrero S.A. & Iglesias A.A. Functional characterization of GDP-mannose pyrophosphorylase from Leptospira interrogans serovar Copenhageni. Archives of Microbiology, 2010, 192, 103–114. [CrossRef] [PubMed]
  2. Case D.A., Darden T.A., Cheatham Iii T.E., Simmerling C.L., Wang J., Duke R.E., Luo R., Merz K.M., Wang B., Pearlman D.A., Crowley M., Brozell S., Tsui V., Gohlke H., Mongan J., Hornak V., Cui G., Beroza P., Schafmeister C., Caldwell J.W., Ross W.S. & Kollman P.A. AMBER 8 Users’ manual. University of California, San Francisco, 2004, 308 p.
  3. Croft S.L., Sundar S. & Fairlamb A.H. Drug resistance in leishmaniasis. Clinical Microbiology Reviews, 2006, 19, 111–126. [CrossRef] [PubMed]
  4. Descoteaux A. & Turco S.J. Glycoconjugates in Leishmania infectivity. Biochimica et Biophysica Acta, 1999, 1455, 341–352. [CrossRef] [PubMed]
  5. Garami A. & Ilg T. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not viability. Journal of European Molecular Biology Organization, 2001, 20, 3657–3666.
  6. Henikoff S. & Henikoff J.G. Amino acid substitution matrices from protein blocks. Proceedings of National Academy of Sciences of the United States of America, 1992, 89, 10915–10919. [CrossRef]
  7. Jones G., Willett P., Glen R.C., Leach A.R. & Taylor R. Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 1997, 267, 727–748. [CrossRef] [PubMed]
  8. Lackovic K., Parisot J.P., Sleebs N., Baell J.B., Debien L., Watson K.G., Curtis J.M., Handman E., Street I.P. & Kedzierski L. Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by highthroughput screening of small-molecule chemical library. Antimicrobial Agents and Chemotherapy, 2010, 54, 1712–1719. [CrossRef] [PubMed]
  9. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J. & Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics, 2007, 23, 2947–2948. [CrossRef] [PubMed]
  10. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F. & Sali A. Comparative protein structure modeling of genes and genomes. Annual Review of Biophysics & Biomolecular Structure, 2000, 29, 291–325. [CrossRef]
  11. Pelissier M.C., Lesley S.A., Kuhn P. & Bourne Y. Structural insights into the catalytic mechanism of bacterial guanosine- diphospho-D-mannose pyrophosphorylase and its regulation by divalent ions. Journal of Biological Chemistry, 2010, 285, 27468–27476. [CrossRef]
  12. Perugini M.A., Griffin M.D.W., Smith B.J., Webb L.E., Davis A.J., Handman E. & Gerrard J.A. Insight into the self-association of key enzymes from pathogenic species. European Biophysics Journal, 2005, 34, 469–476. [CrossRef]
  13. Stewart J., Curtis J., Spurck T.P., Ilg T., Garami A., Baldwin T., Courret N., McFadden G.I., Davis A. & Handman E. Charaterization of a Leishmania mexicana knockout lacking guanosine diphosphate-mannose pyrophosphorylase. International Journal for Parasitology, 2005, 35, 861–873. [CrossRef] [PubMed]
  14. Varki A. Glycan-based interactions involving vertebrate sialicacid recognizing proteins. Nature, 2007, 446, 1023–1029. [CrossRef] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.